CTOs on the Move

MedeAnalytics

www.medeanalytics.com

 
MedeAnalytics provides evidence-based insights to solve a real problem that plagues health care – how to use the immense amount of patient data collected along the care continuum to deliver cost – effective care and promote a healthier population. The platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics` cloud-based tools have been used to analyze more than 21 billion patient encounters in the United States ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.medeanalytics.com
  • 501 W President George Bush Highway Suite 250
    Richardson, TX USA 75080
  • Phone: 469.916.3300

Executives

Name Title Contact Details
Sree Ghantasala
Chief Technology Officer Profile
Atahan Bozdag
Director, Information Security and Risk Profile
Scott Checkoway
Chief Information Officer Profile
Cindi Carter
Chief Security Officer Profile
Tyler Downs
Chief Technology Officer Profile

Similar Companies

Texas Osteopathic Medical

Texas Osteopathic Medical is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DOCTORS HOSPITAL WEST COVINA

DOCTORS HOSPITAL WEST COVINA is a West Covina, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bach Mobilities Inc

Bach Mobilities Inc is a Escanaba, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Catalyst Biosciences

Catalyst Biosciences is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in South San Francisco, CA. To find more information about Catalyst Biosciences, please visit www.catbio.com

Dako

DAKO is a fully integrated, global provider of cancer diagnostic and research products for pathology and oncology. The Company's products utilize antibodies, nucleic acid probes, and proprietary detection technologies to identify specific